Literature DB >> 29954761

Disseminated histoplasmosis mimicking relapsed chronic lymphocytic leukaemia.

Lokesh Shahani1.   

Abstract

Histoplasma microconidia when inhaled are presented in antigenic form to T cells, limiting the extent of infection; however, defects in cellular immunity results in disseminated disease. Chronic lymphocytic leukaemia (CLL) is a lymphoproliferative disorder resulting in functionally impaired lymphocytes, predisposing patients to various opportunistic infections. The author reports a recently treated patient with CLL presenting with constitutional symptoms accompanied by hepatosplenomegaly and diffuse adenopathy. Considering the recent diagnosis and treatment of CLL, initial suspicion was relapsed disease. However, considering the immune deficiency associated with CLL and its treatment, infectious aetiologies were strongly considered. Further investigation revealed a case of disseminated histoplasmosis mimicking CLL in this reported patient. Considering appropriate diagnosis and timely therapy, the reported patient had good prognosis despite being diagnosed with disseminated histoplasmosis. This case highlights consideration of disseminated histoplasmosis in patients presenting with diffuse adenopathy along with hepatomegaly and/or splenomegaly in the right clinical setting. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  haematology (incl blood transfusion); infectious diseases

Mesh:

Substances:

Year:  2018        PMID: 29954761      PMCID: PMC6040541          DOI: 10.1136/bcr-2018-224498

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Geographic variation in the prevalence of histoplasmin sensitivity.

Authors:  N E MANOS; S H FEREBEE; W F KERSCHBAUM
Journal:  Dis Chest       Date:  1956-06

Review 2.  Histoplasmosis: a clinical and laboratory update.

Authors:  Carol A Kauffman
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  A multicenter evaluation of tests for diagnosis of histoplasmosis.

Authors:  Chadi A Hage; Julie A Ribes; Nancy L Wengenack; Larry M Baddour; Maha Assi; David S McKinsey; Kassem Hammoud; Daisy Alapat; N Esther Babady; Michelle Parker; DeAnna Fuller; Aliya Noor; Thomas E Davis; Mark Rodgers; Patricia A Connolly; Boutros El Haddad; L Joseph Wheat
Journal:  Clin Infect Dis       Date:  2011-08-02       Impact factor: 9.079

4.  Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia.

Authors:  Xavier C Badoux; Michael J Keating; Xuemei Wang; Susan M O'Brien; Alessandra Ferrajoli; Stefan Faderl; Jan Burger; Charles Koller; Susan Lerner; Hagop Kantarjian; William G Wierda
Journal:  Blood       Date:  2011-06-13       Impact factor: 22.113

Review 5.  Revisiting old friends: Developments in understanding Histoplasma capsulatum pathogenesis.

Authors:  Jon P Woods
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

6.  Disseminated histoplasmosis: abdominal CT findings in 16 patients.

Authors:  D R Radin
Journal:  AJR Am J Roentgenol       Date:  1991-11       Impact factor: 3.959

7.  Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America.

Authors:  L Joseph Wheat; Alison G Freifeld; Martin B Kleiman; John W Baddley; David S McKinsey; James E Loyd; Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2007-08-27       Impact factor: 9.079

8.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

Authors:  Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti R Rai; Thomas J Kipps
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

Review 9.  Histoplasma capsulatum, lung infection and immunity.

Authors:  Michael C Horwath; Roger A Fecher; George S Deepe
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

10.  Infectious complications in chronic lymphocytic leukemia.

Authors:  Annamaria Nosari
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-11-05       Impact factor: 2.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.